AW
DEAD

Serial Number

85843330

Owner

ACTAVIS, INC.

Attorney

GABRIELLE S. ROTH

Filing Date

Feb 7, 2013

Add to watchlist:

No watchlists yet
View on USPTO

AW Trademark

Serial Number: 85843330

AW is a trademark filed by ACTAVIS, INC. on February 7, 2013. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ACTAVIS, INC. (216 trademarks)

400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Entity Type: 03

ACTAVIS HOLDCO US, INC. (65 trademarks)

PARSIPPANY, NJ 07054

Entity Type: 03

Trademark Details

Filing Date

February 7, 2013

Registration Date

Not Registered

Published for Opposition

October 29, 2013

Goods & Services

Educational services, namely, conducting conferences, seminars, webinars, video case studies, classes and workshops in the fields of healthcare, women's health, pharmaceuticals and medicine, pharmaceutical research and development

Pharmaceutical preparations for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatogical diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators; pharmaceutical preparations for the prevention and treatment of sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations, pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels, pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); dental wax; medicated dental rinses, mouth rinses and mouthwashes, medicated chewing gum, medicated dental lozenges and tablets; medicated preparations for the care of mouth and teeth; diagnostic test kits for home use for women's health, reproduction and infertility, cardio-vascular system and the immune system, pregnancy test kits for home use, ovulation test kits for home use, in-vitro ovulation prediction test kits for home use, diagnostic test kits for home use for detecting urinary tract infections, diagnostic test kits for home use for detecting menopause, diagnostic test kits for detecting vaginal pH balances, and diagnostic test kits for detecting sexually-transmitted diseases,all principally composed of chemical reagents or chemically treated papers for detecting such diseases or conditions; dietary supplements for humans

Soaps; perfumery; essential oils; cosmetics; cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, ointments, gels, skin fresheners, toners, cleansers and peels for skin care, cosmetic preparations for the hair and scalp; moisturizing preparations for the skin; non-medicated skin care preparations; skin care creams, lotions, ointments, gels, skin fresheners, toners, cleansers and peels; hair shampoos, hair lotions, and hair conditioners; dentifrices; non-medicated dental rinses, mouth rinses and mouth washes; dentifrices in the form of chewing gum, non-medicated dental lozenges and tablets used to freshen breath and to relieve symptoms of dry mouth; breath fresheners; dentifrices in the form of mouth sprays; cosmetic preparations for the care of mouth and teeth

Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals, chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industry

Surgical, medical, dental and veterinary apparatus and instruments, namely, diagnostic test kits principally composed of medical diagnostic meters that measure conditions of the cardio-vascular and immune systems

Scientific and technological services, namely, consulting in the field of pharmaceuticals and medicine, pharmaceutical research and development; industrial analysis and research services in the field of pharmaceuticals and chemical analysis

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 22, 2017 ASGN
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 30, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 30, 2017 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2016 EXRA
SOU EXTENSION 5 GRANTED
Jun 19, 2016 EX5G
SOU EXTENSION 5 FILED
Jun 2, 2016 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 2, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 27, 2016 EXRA
SOU EXTENSION 4 GRANTED
Jan 26, 2016 EX4G
SOU EXTENSION 4 FILED
Dec 16, 2015 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 16, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 3, 2015 EXRA
SOU EXTENSION 3 GRANTED
Jul 2, 2015 EX3G
SOU EXTENSION 3 FILED
Jun 22, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 22, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 17, 2015 EXRA
SOU EXTENSION 2 GRANTED
Feb 14, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 12, 2015 AITU
SOU EXTENSION 2 FILED
Dec 22, 2014 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 22, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 6, 2014 EXRA
SOU EXTENSION 1 GRANTED
Jun 4, 2014 EX1G
SOU EXTENSION 1 FILED
Jun 4, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 4, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 24, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 29, 2013 NPUB
PUBLISHED FOR OPPOSITION
Oct 29, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 9, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 21, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 19, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 19, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 19, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 19, 2013 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Aug 16, 2013 GPRN
PRIORITY ACTION E-MAILED
Aug 16, 2013 GPRA
PRIORITY ACTION WRITTEN
Aug 16, 2013 CPRA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 15, 2013 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 5, 2013 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 24, 2013 PREV
ASSIGNED TO LIE
Jul 12, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 19, 2013 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 30, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 30, 2013 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 16, 2013 GNRN
NON-FINAL ACTION E-MAILED
May 16, 2013 GNRT
NON-FINAL ACTION WRITTEN
May 16, 2013 CNRT
ASSIGNED TO EXAMINER
May 13, 2013 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 14, 2013 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 13, 2013 NWOS
NEW APPLICATION ENTERED
Feb 11, 2013 NWAP